Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
326 studies found for:    Open Studies | kidney transplantation
Show Display Options
Rank Status Study
21 Recruiting Induction With SVF Derived MSC in Living-related Kidney Transplantation
Condition: Living-relative Kidney Transplantation
Interventions: Procedure: SVF-MSC induction;   Drug: Basiliximab induction
22 Recruiting Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation
Conditions: Delayed Graft Function;   Kidney Transplantation;   Complement Activity
Interventions: Drug: Eculizumab;   Drug: Normal Saline
23 Recruiting Pre-emptive Kidney Transplantation Quality of Life
Conditions: Renal Insuffiency;   Kidney Transplantation
Intervention: Other: Questionnaires : Patient-Reported Outcomes
24 Recruiting Screening Latent Tuberculosis Infection and Observing Preventive Therapy in Kidney Transplantation
Condition: Kidney Transplantation
Intervention: Other: Examination of latent tuberculosis
25 Recruiting Pre-formed Alloreactivity in Renal Transplant Recipients
Conditions: Kidney Transplantation;   Acute Graft Rejection
Intervention:
26 Recruiting Mesenchymal Stromal Cells in Kidney Transplant Recipients
Condition: Kidney Transplant Rejection
Intervention: Biological: Mesenchymal Stromal Cells
27 Recruiting MSC and Kidney Transplant Tolerance (Phase A)
Condition: Chronic Renal Failure
Intervention: Biological: Mesenchymal Stromal Cells
28 Recruiting Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Conditions: Acute Rejection (AR) of Transplanted Kidney;   Chronic Allograft Nephropathy (CAN);   Interstitial Fibrosis (IF);   Tubular Atrophy (TA)
Intervention:
29 Recruiting Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
Condition: Implant or Graft; Rejection
Interventions: Drug: Belatacept;   Drug: Tacrolimus;   Drug: Mycophenolate;   Drug: rATG;   Drug: Methylprednisolone;   Procedure: Renal transplant
30 Recruiting Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant
Condition: End Stage Renal Disease
Intervention: Behavioral: Expert System Coaching
31 Recruiting Evaluation of CAF22 After Renal Transplantation
Conditions: Kidney Transplantation;   Delayed Graft Function
Intervention: Other: Blood and urine sampling
32 Recruiting Use of Immune Globulin (IVIG) Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation
Condition: End Stage Renal Disease
Intervention: Biological: Rituxan
33 Not yet recruiting Contrast-Enhanced Ultrasound for Kidney Transplant
Condition: Kidney Transplantation
Intervention: Drug: Lumason Contrast-Enhanced Ultrasound
34 Recruiting Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Conditions: Asymptomatic Bacteriuria;   Pyelonephritis
Interventions: Drug: Antibiotic treatment;   Other: No treatment
35 Recruiting Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Conditions: Chronic Kidney Disease;   Acute Myeloid Leukemia (AML);   Acute Lymphoblastic Leukemia (ALL);   Chronic Myelogenous Leukemia (CML);   Chronic Lymphocytic Leukemia (CLL);   Non-Hodgkin's Lymphoma (NHL);   Hodgkin Disease;   Multiple Myeloma;   Myelodysplastic Syndrome (MDS);   Aplastic Anemia;   AL Amyloidosis;   Diamond Blackfan Anemia;   Myelofibrosis;   Myeloproliferative Disease;   Sickle Cell Anemia;   Autoimmune Diseases;   Thalassemia
Intervention: Procedure: Haploidentical Bone Marrow/Kidney
36 Not yet recruiting Teen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1)
Condition: Medication Adherence
Intervention: Other: Focus Group
37 Recruiting Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP)
Condition: End Stage Renal Diseases
Intervention: Procedure: HEMO2Life® use in organ preservation solution
38 Recruiting The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
Condition: Resistant Hypertension in Kidney Transplant Patients
Intervention: Drug: Chlorthalidone
39 Recruiting Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.
Conditions: Renal Transplant Recipient;   Immunized Against the Cytomegalovirus
Intervention: Biological: CMV Infection
40 Not yet recruiting Effects of Preventive Negative Pressure Wound Therapy With PICO on Surgical Wounds of Kidney Transplant Patients
Condition: Wound Complications
Intervention: Device: portable (pocket) negative pressure wound treatment device

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.